- Home
- BEATW vs UUU Comparison
BEATW vs UUU Comparison
Compare BEATW & UUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEATW
- UUU
- Stock Information
- Founded
- BEATW 2015
- UUU 1969
- Country
- BEATW United States
- UUU United States
- Employees
- BEATW 21
- UUU N/A
- Industry
- BEATW Retail: Computer Software & Peripheral Equipment
- UUU Electronic Components
- Sector
- BEATW Technology
- UUU Technology
- Exchange
- BEATW Nasdaq
- UUU Nasdaq
- Market Cap
- BEATW N/A
- UUU N/A
- IPO Year
- BEATW N/A
- UUU N/A
- Fundamental
- Price
- BEATW $0.60
- UUU $2.20
- Analyst Decision
- BEATW
- UUU
- Analyst Count
- BEATW 0
- UUU 0
- Target Price
- BEATW N/A
- UUU N/A
- AVG Volume (30 Days)
- BEATW 4.7K
- UUU 37.2K
- Earning Date
- BEATW 03-14-2025
- UUU 02-14-2025
- Dividend Yield
- BEATW N/A
- UUU N/A
- EPS Growth
- BEATW N/A
- UUU N/A
- EPS
- BEATW N/A
- UUU N/A
- Revenue
- BEATW N/A
- UUU $22,168,402.00
- Revenue This Year
- BEATW N/A
- UUU N/A
- Revenue Next Year
- BEATW N/A
- UUU N/A
- P/E Ratio
- BEATW N/A
- UUU N/A
- Revenue Growth
- BEATW N/A
- UUU 5.57
- 52 Week Low
- BEATW $0.50
- UUU $1.11
- 52 Week High
- BEATW $0.62
- UUU $2.47
- Technical
- Relative Strength Index (RSI)
- BEATW N/A
- UUU 68.53
- Support Level
- BEATW N/A
- UUU $1.90
- Resistance Level
- BEATW N/A
- UUU $2.20
- Average True Range (ATR)
- BEATW 0.00
- UUU 0.18
- MACD
- BEATW 0.00
- UUU 0.05
- Stochastic Oscillator
- BEATW 0.00
- UUU 93.22
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.